 |
|
Fourteen Anti-vascular Endothelial Growth Factor Injections for Age-related Macular Degeneration: Ending Period and Clinical Outcome.
Jae Wook Han, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jung Il Han, Young Ju Lew, Jae Hui Kim
J Korean Ophthalmol Soc. 2017;58(9):1042-1049. Published online 2017 Sep 15 DOI: https://doi.org/10.3341/jkos.2017.58.9.1042
|
|
Citations to this article as recorded by
 Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration
Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2021; 62(8): 1076. CrossRef Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration
Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2021; 62(9): 1218. CrossRef Effect of epidermal growth factor ointment on persistent epithelial defects of the cornea
Hyun Sik Moon, Lan Li, Hyeon Jeong Yoon, Yong Sok Ji, Kyung Chul Yoon
BMC Ophthalmology.2020;[Epub] CrossRef
|